A recent study designed and implemented by investigators at Cedars-Sinai found that artificial intelligence (AI) can accurately evaluate cardiovascular risk during a routine chest computed tomography (CT) scan without contrast.
Cedars-Sinai investigators have identified significant variations in the microbes of the small bowel (small intestine) are strongly associated with various body weights, from a normal body mass index, or BMI, to having obesity.
Cedars-Sinai investigators have discovered how brain cells responsible for working memory—the type required to remember a phone number long enough to dial it—coordinate intentional focus and short-term storage of information.
Using spatial analysis of tissue samples, Cedars-Sinai investigators have identified patterns that could predict whether patients with the most common type of ovarian cancer will experience early relapse after treatment.
Every day, scientists across Cedars-Sinai’s vast research and clinical enterprise are focused on developing medical discoveries and breakthroughs to improve health outcomes.
Bin Zheng, PhD, a specialist in targeted therapies and immunotherapy, has joined Cedars-Sinai Cancer as director of Melanoma Research in the Department of Biomedical Sciences. Zheng will work with Cedars-Sinai surgical and medical oncology leadership to develop and lead a comprehensive translational and basic science research program for melanoma.
Neuroprosthetics, a technology that allows the brain to control external devices such as robotic limbs, is beginning to emerge as a viable option for patients disabled by amputation or neurological conditions such as stroke.
Cedars-Sinai está ampliando la atención médica virtual para niños e hispanohablantes en California a través de su aplicación móvil Cedars-Sinai Connect, una opción en línea de rápido crecimiento que permite a los pacientes acceder rápidamente a los mejores profesionales sanitarios para la atención aguda, crónica y preventiva.
Cedars-Sinai has joined a White House initiative aimed at ensuring healthcare providers and companies use artificial intelligence (AI) ethically and responsibly. Together with the U.S. Department of Health and Human Services, the AI effort—announced in late 2023—is a consortium involving nearly 40 health systems and insurers.
Cedars-Sinai is expanding virtual healthcare for children and Spanish speakers in California through its mobile app Cedars-Sinai Connect, a fast-growing online option that allows patients to quickly access top healthcare professionals for acute, chronic and preventive care.
Black women in the U.S. are three times more likely than white women to die, or become seriously ill, from pregnancy-related complications, according to the Centers for Disease Control and Prevention. Addressing the complexity of causes behind poor health outcomes for Black mothers requires commitment, investment and innovation to produce measurable change.
Cedars-Sinai and BlackDoctor.org will host an important virtual conversation about the state of Black maternal mental health and address the importance of early diagnosis and access to effective treatment.
Cedars-Sinai neurologists specializing in stroke, neuropalliative care, multiple sclerosis, autoimmune and movement disorders will present leading-edge research and discuss the latest patient-care options at the American Academy of Neurology Annual Meeting April 13-18 in Denver.
Investigators with Cedars-Sinai Guerin Children’s and other research institutions have identified a process responsible for the development of teeth called incisors—a discovery that could one day improve understanding of how birth defects happen.
Curtis L. Cetrulo Jr., MD, vice chair of Research in the Department of Surgery and director of the Division of Plastic Surgery, has been selected as the General William and Willa Dean Lyon Family Chair in Reconstructive and Plastic Surgery.
Experts from the Smidt Heart Institute at Cedars-Sinai will share new research and participate in more than 70 discussions during the American College of Cardiology (ACC) Annual Scientific Session April 6-8 in Atlanta.
This study, led by investigators in the Smidt Heart Institute at Cedars-Sinai, applies novel artificial intelligence (AI) methods to measure heart function.
When Elisa Schoenfeld, a child development specialist, learned she had tested positive for a BRCA gene mutation, she knew it raised her risk for breast and ovarian cancer. She and her daughter, Amira, who received similar genetic test results, visited the BRCA Ovarian Previvor Clinic at Cedars-Sinai.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for March 2024.
Cedars-Sinai Cancer investigators attending the American Association for Cancer Research Annual Meeting April 5-10 in San Diego are available to comment on scientific advances being presented throughout the conference.
In a new study, Cedars-Sinai Cancer investigators explored malpractice trends related to active surveillance as a treatment strategy across cancers. They found that to date, there has been no successful litigation related to active surveillance.
New research from Cedars-Sinai suggests people who are scheduled for certain medical procedures should stop taking popular weight loss drugs in the days or weeks prior to avoid complications.
Actress, singer and songwriter, Mckenna Grace, 17, is having a moment in the spotlight with the upcoming opening of Ghostbusters: Frozen Empire. Her path to the big screen, however, is not the typical Hollywood story.
Artist Syril Strickler was 47 when she had her first epileptic seizure, waking up in the hospital after neighbors found her unconscious in the street. For 10 years, seizures every few weeks brought her life to a virtual standstill—until Cedars-Sinai physicians performed a surgery that gave Strickler her life back.
It is one of the most common and painful disorders, affecting more than 6 million women in the United States. Endometriosis is often difficult to diagnose and effectively treat. But Cedars-Sinai experts find patients can now benefit from minimally invasive procedures, medications and integrative medicine.
From artificial intelligence (AI) and data integration to natural language processing and statistics, the Cedars-Sinai Department of Computational Biomedicine is utilizing the latest technological advances to find solutions to some of the most complex healthcare issues.
Investigators at Cedars-Sinai have identified risk factors that make inflammatory bowel disease (IBD) patients susceptible to developing serious conditions in other parts of their bodies.
One group is using machine learning to develop a more reliable and efficient screening method for bladder cancer.
For the fourth consecutive year, the Blood and Marrow Transplant Program in the Division of Hematology and Cellular Therapy at Cedars-Sinai has achieved higher than expected survival rates in patients receiving allogeneic stem cell transplantation, according to a recent report from the Center for International Blood and Marrow Transplant Research.
In its latest global expansion, Cedars-Sinai International announced the opening of its new global office in Singapore.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
